{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:13:56Z","timestamp":1790367236321,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.psychres.2023.115364","type":"journal-article","created":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T09:41:57Z","timestamp":1690105317000},"page":"115364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics"],"prefix":"10.1016","volume":"326","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0501-3073","authenticated-orcid":false,"given":"C","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TA","family":"Tishler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KH","family":"Nuechterlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-6640","authenticated-orcid":false,"given":"BM","family":"Ellingson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.psychres.2023.115364_bib0001","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1038\/npp.2015.90","article-title":"Progressive brain atrophy and cortical thinning in schizophrenia after commencing clozapine treatment","volume":"40","author":"Ahmed","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2023.115364_bib0002","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00406-006-0667-1","article-title":"Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study","volume":"256","author":"Albus","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.psychres.2023.115364_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.schres.2022.02.019","article-title":"The Disease Recovery Evaluation and Modification (DREaM) study: effectiveness of paliperidone palmitate versus oral antipsychotics in patients with recent-onset schizophrenia or schizophreniform disorder","volume":"243","author":"Alphs","year":"2022","journal-title":"Schizophr. Res."},{"issue":"4","key":"10.1016\/j.psychres.2023.115364_bib0004","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0893-133X(02)00364-0","article-title":"Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation","volume":"27","author":"Bartzokis","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.psychres.2023.115364_bib0005","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/j.neuropharm.2012.01.015","article-title":"Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments","volume":"62","author":"Bartzokis","year":"2012","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.psychres.2023.115364_bib0006","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2011.06.029","article-title":"Long acting injection versus oral risperidone in first-episode schizophrenia: differential impact on white matter myelination trajectory","volume":"132","author":"Bartzokis","year":"2011","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2023.115364_bib0007","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2012.06.036","article-title":"Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia","volume":"140","author":"Bartzokis","year":"2012","journal-title":"Schizophr. Res."},{"issue":"1\u20133","key":"10.1016\/j.psychres.2023.115364_bib0008","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2012.06.036","article-title":"Impact on intracortical myelination trajectory of long acting injection versus oral risperidone in first-episode schizophrenia","volume":"140","author":"Bartzokis","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2\u20133","key":"10.1016\/j.psychres.2023.115364_bib0009","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.schres.2009.06.014","article-title":"In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia","volume":"113","author":"Bartzokis","year":"2009","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.psychres.2023.115364_bib0010","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/NMD.0000000000000286","article-title":"Brain imaging during the transition from psychosis prodrome to schizophrenia","volume":"203","author":"Chung","year":"2015","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2023.115364_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2020.03.073","article-title":"Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients","author":"Chwa","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115364_bib0012","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.schres.2020.03.073","article-title":"Association between cortical volume and gray-white matter contrast with second generation antipsychotic medication exposure in first episode male schizophrenia patients","volume":"222","author":"Chwa","year":"2020","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.psychres.2023.115364_bib0013","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/nimg.1998.0395","article-title":"Cortical surface-based analysis. I. Segmentation and surface reconstruction","volume":"9","author":"Dale","year":"1999","journal-title":"Neuroimage"},{"issue":"16","key":"10.1016\/j.psychres.2023.115364_bib0014","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1017\/S0033291717001313","article-title":"White matter connectivity disruptions in early and chronic schizophrenia","volume":"47","author":"Di Biase","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115364_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbad040","article-title":"Two neuroanatomical signatures in schizophrenia: expression strengths over the first 2 years of treatment and their relationships to neurodevelopmental compromise and antipsychotic treatment","author":"du Plessis","year":"2023","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.psychres.2023.115364_bib0016","first-page":"1","article-title":"Antipsychotic treatment effects and structural MRI brain changes in schizophrenia","volume":"53","author":"Emsley","year":"2021","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2023.115364_bib0017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pscychresns.2019.01.003","article-title":"Subcortical structures and cognitive dysfunction in first episode schizophrenia","volume":"286","author":"Fan","year":"2019","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"20","key":"10.1016\/j.psychres.2023.115364_bib0018","doi-asserted-by":"crossref","first-page":"11050","DOI":"10.1073\/pnas.200033797","article-title":"Measuring the thickness of the human cerebral cortex from magnetic resonance images","volume":"97","author":"Fischl","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"32","key":"10.1016\/j.psychres.2023.115364_bib0019","doi-asserted-by":"crossref","first-page":"11597","DOI":"10.1523\/JNEUROSCI.2180-11.2011","article-title":"Mapping human cortical areas in vivo based on myelin content as revealed by T1- and T2-weighted MRI","volume":"31","author":"Glasser","year":"2011","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.psychres.2023.115364_bib0020","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archgenpsychiatry.2009.24","article-title":"Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability","volume":"66","author":"Goldman","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115364_bib0021","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41380-018-0231-1","article-title":"Memory and cognition in schizophrenia","volume":"24","author":"Guo","year":"2019","journal-title":"Mol. Psychiatry"},{"issue":"10","key":"10.1016\/j.psychres.2023.115364_bib0022","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archpsyc.56.10.905","article-title":"Reduced gray matter volume in schizophrenia","volume":"56","author":"Gur","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2023.115364_bib0023","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1176\/appi.ajp.162.12.2233","article-title":"Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies","volume":"162","author":"Honea","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2023.115364_bib0024","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1017\/S0033291797006041","article-title":"Executive function in first-episode schizophrenia","volume":"28","author":"Hutton","year":"1998","journal-title":"Psychol. Med."},{"issue":"9","key":"10.1016\/j.psychres.2023.115364_bib0025","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1017\/S0033291716000593","article-title":"Increased MRI-based cortical grey\/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder","volume":"46","author":"Jorgensen","year":"2016","journal-title":"Psychol. Med."},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2023.115364_bib0026","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","article-title":"Dose equivalents for antipsychotic drugs: the DDD method","volume":"42","author":"Leucht","year":"2016","journal-title":"Schizophr. Bull."},{"issue":"11","key":"10.1016\/j.psychres.2023.115364_bib0027","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/S0006-3223(01)01303-8","article-title":"The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches","volume":"50","author":"Lieberman","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.psychres.2023.115364_bib0028","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.psychres.2023.115364_bib0029","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0014708","article-title":"Neurocognition in first-episode schizophrenia: a meta-analytic review","volume":"23","author":"Mesholam-Gately","year":"2009","journal-title":"Neuropsychology"},{"issue":"1","key":"10.1016\/j.psychres.2023.115364_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2004.09.007","article-title":"Identification of separable cognitive factors in schizophrenia","volume":"72","author":"Nuechterlein","year":"2004","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2023.115364_bib0031","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.biopsych.2011.11.026","article-title":"Cortical volume, surface area, and thickness in schizophrenia and bipolar disorder","volume":"71","author":"Rimol","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115364_bib0032","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fnins.2015.00396","article-title":"Assessing intracortical myelin in the living human brain using myelinated cortical thickness","volume":"9","author":"Rowley","year":"2015","journal-title":"Front. Neurosci."},{"issue":"7","key":"10.1016\/j.psychres.2023.115364_bib0033","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/cercor\/bhh032","article-title":"Thinning of the cerebral cortex in aging","volume":"14","author":"Salat","year":"2004","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.psychres.2023.115364_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroimage.2018.10.023","article-title":"Depth-dependent intracortical myelin organization in the living human brain determined by in vivo ultra-high field magnetic resonance imaging","volume":"185","author":"Sprooten","year":"2019","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.psychres.2023.115364_bib0035","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/appi.ajp.2010.09010087","article-title":"Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia","volume":"168","author":"Subotnik","year":"2011","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2023.115364_bib0036","first-page":"454","article-title":"Abnormal trajectory of intracortical myelination in schizophrenia implicates white matter in disease pathophysiology and the therapeutic mechanism of action of antipsychotics","volume":"3","author":"Tishler","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.psychres.2023.115364_bib0037","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2023.03.023","article-title":"Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: magnetic resonance imaging results from the DREaM study","volume":"255","author":"Tishler","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115364_bib0038","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neubiorev.2017.08.022","article-title":"Comprehensive review: computational modelling of schizophrenia","volume":"83","author":"Valton","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"4","key":"10.1016\/j.psychres.2023.115364_bib0039","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/mp.2015.63","article-title":"Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium","volume":"21","author":"van Erp","year":"2016","journal-title":"Mol. Psychiatry"},{"issue":"9","key":"10.1016\/j.psychres.2023.115364_bib0040","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archgenpsychiatry.2011.88","article-title":"Changes in cortical thickness during the course of illness in schizophrenia","volume":"68","author":"van Haren","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2023.115364_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biopsych.2019.09.004","article-title":"Neuroimaging Heterogeneity in Psychosis: neurobiological Underpinnings and Opportunities for Prognostic and Therapeutic Innovation","volume":"88","author":"Voineskos","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2023.115364_bib0042","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.schres.2023.03.040","article-title":"Prospective, randomized, multicenter clinical trial evaluating longitudinal changes in brain function and microstructure in first-episode schizophrenia patients treated with long-acting injectable paliperidone palmitate versus oral antipsychotics","volume":"255","author":"Wang","year":"2023","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2023.115364_bib0043","series-title":"Contemporary Issues in the Treatment of Schizophrenia","first-page":"411","article-title":"Recognition and management of neuroleptic noncompliance","author":"Weiden","year":"1995"},{"key":"10.1016\/j.psychres.2023.115364_bib0044","article-title":"Dispersion of cognitive performance test scores on the MATRICS Consensus Cognitive Battery: a different perspective","volume":"30","author":"Williamson","year":"2022","journal-title":"Schizophr. Res. Cogn."},{"issue":"2","key":"10.1016\/j.psychres.2023.115364_bib0045","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12264-014-1502-8","article-title":"Prefrontal cortex and the dysconnectivity hypothesis of schizophrenia","volume":"31","author":"Zhou","year":"2015","journal-title":"Neurosci. Bull."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178123003141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T06:08:37Z","timestamp":1759039717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178123003141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":45,"alternative-id":["S0165178123003141"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115364","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortical thickness, gray-white matter contrast, and intracortical myelin in first-episode schizophrenia patients treated with long-acting paliperidone palmitate versus oral antipsychotics","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2023.115364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115364"}}